Pegara is a California-based eHealth startup founded in Sep, 2015 by Japanese founders, aiming to tackle the alarming increase of Alzheimer's and other memory impairing diseases. The company offers the innovative "Life-changing Program", particularly targeting middle-aged women, to reduce the risk of developing Alzheimer's disease by as much as 53% utilizing the scientifically proven principles of the MIND Diet. With the "Brainsalvation Dietary Program", Pegara aims to promote a healthy dietary lifestyle. Their "Risk Reduction Score" provides a clear guideline, free of charge, for individuals to understand how lifestyle choices impact the potential development of dementia and/or Alzheimer's. Alzheimer's holds a significant threat, affecting almost 5.2 million Americans aged 65 and older, with a potential to triple by 2050. Pegara's focus on lifestyle choices and preventive measures is especially relevant given the high failure rates (reaching 99.6%) in Alzheimer's drug development. By focusing on dietary and lifestyle adjustments, Pegara aims to fill the gap in Alzheimer's prevention and treatment. Pegara received a $1.04M Seed Round investment on 12 September 2019, with investment from A.L.I. Technologies Japan, MIRAISE, and Hu Hua. Despite the challenging market and the complexity of the issue they are addressing, Pegara's innovative approach and potential impact make it an attractive prospect for future investment and success.